BioPlus' website gets new look Gilead to acquire CGI BI: Linagliptin significantly lowers blood glucose levels Bayer launches mobile app for hemophilia patients MannKind presents Afrezza study at scientific meeting FDA approves OraSure Technologies’ hepatitis C test Metabolex, Sanofi-Aventis announce new partnership Cephalon expands When Good Medicines Become Bad Drugs program with new partnership FDA approves Lucentis for vision loss-related disease Orphan drug designation for Tolera's diabetes drug First Previous 189 190 191 192 193 Next Last
